Version history

{
  "session_id": "sess_SDA-2026-04-08-gap-pubmed-20260406-062212-6777e5dd_task_9aae8fc5",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "scidex.core.llm.complete",
  "action": "propose",
  "content": "# Therapeutic Hypotheses: Neuron-Specific Autophagy Defects in ALS\n\n---\n\n## Hypothesis 1: Axonal Transport Defect in Autophagosome Maturation\n\n**Title:** C9orf72 hexanucleotide expansion impairs retrograde autophagosome transport in motor neuron axons\n\n**Mechanism:** C9orf72 forms a complex with RAB7 and the dynein-dynactin motor complex to regulate autophagosome retrograde transport. GGGGCC repeat expansions cause C9orf72 haploinsufficiency, disrupting this complex and trapping immature autophagosomes in the distal axon. This creates a \"traffic jam\" preventing delivery of autophagic cargo to the soma for lysosomal degradation.\n\n**Target gene/protein/pathway:** C9orf72 → RAB7A → dynein-dynactin complex → microtubule network\n\n**Supporting evidence:**\n- C9orf72 regulates Rab-mediated membrane trafficking (PMID: 25403846)\n- C9orf72 interacts with RAB7L1 and autophagy regulators (PMID: 25920554)\n- iPSC-derived motor neurons from C9orf72 patients show axonal autophagosome accumulation (PMID: 29530934)\n\n**Predicted experiment:** Live-cell imaging of mCherry-eGFP-LC3B autophagosomes in iPSC-derived motor neurons from C9orf72 expansion carriers vs. isogenic controls, measuring axonal transport velocity, flux, and fusion events at distal vs. proximal compartments using microfluidic chambers.\n\n**Confidence:** 0.78\n\n---\n\n## Hypothesis 2: Motor Neuron-Specific Mitophagy Failure via OPTN-TBK1 Axis\n\n**Title:** OPTN/TBK1 mutations create selective vulnerability by blocking PINK1-Parkin-independent mitophagy in lower motor neurons\n\n**Mechanism:** OPTN serves as the primary autophagy receptor for damaged mitochondria in neurons via its LC3-interacting region (LIR) and ubiquitin-binding domain. TBK1 phosphorylates OPTN at S177, enhancing its affinity for ubiquitinated mitochondrial proteins. ALS-causing mutations in either gene impair this phospho-regulation, causing accumulation of dysfunctional mitochondria specifically in motor neurons—which have exceptionally high energy demands and limited mitophagy redundancy compared to other cell types.\n\n**Target gene/protein/pathway:** PINK1/PARKIN-independent pathway: TBK1 → OPTN (S177) → LC3G → isolation membrane recruitment\n\n**Supporting evidence:**\n- OPTN mutations cause ALS (PMID: 21109225, 21784250)\n- TBK1 mutations identified in ALS cohorts (PMID: 25241285)\n- OPTN deficiency leads to mitochondrial fragmentation and ROS accumulation (PMID: 29748552)\n- Neurons uniquely depend on OPTN-mediated mitophagy (PMID: 31359046)\n\n**Predicted experiment:** Mito-Keima sensor quantification in spinal motor neurons vs. cortical neurons from OPTN knockout or ALS-mutant knock-in mice following FCCP treatment, with comparative measurement of mitochondrial membrane potential recovery, ROS levels, and ATP production.\n\n**Confidence:** 0.72\n\n---\n\n## Hypothesis 3: TDP-43 Pathology Disrupts SNARE-Mediated Autophagosome-Lysosome Fusion\n\n**Title:** Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-17, blocking autophagosome-lysosome fusion\n\n**Mechanism:** Under pathological conditions, mislocalized TDP-43 aggregates in the cytoplasm sequester the Q-soluble SNARE protein SNAP29 and the R-soluble SNARE syntaxin-17 (STX17), preventing formation of the trans-SNARE complex required for autophagosome-lysosome fusion. This creates a secondary autophagy block independent of initiation, explaining why early-stage ALS shows increased autophagosomes while late-stage shows aggregate accumulation.\n\n**Target gene/protein/pathway:** TDP-43 (TARDBP) → SNAP29 → STX17/VAMP8 SNARE complex → autophagosome-lysosome fusion\n\n**Supporting evidence:**\n- TDP-43 pathology is present in >95% of ALS cases (PMID: 18697238)\n- SNAP29 dysfunction causes neurodevelopmental defects mimicking TDP-43 loss (PMID: 26945057)\n- STX17 localizes to completed autophagosomes; its knockdown mimics ALS autophagy phenotypes (PMID: 26577887)\n- TDP-43 regulates SNAP29 mRNA splicing (PMID: 31138729)\n\n**Predicted experiment:** Co-immunoprecipitation of SNAP29 and STX17 from laser-captured spinal cord motor neurons of ALS patients vs. controls, with validation using in vitro reconstitution assays measuring SNARE complex formation and liposome fusion rates.\n\n**Confidence:** 0.69\n\n---\n\n## Hypothesis 4: VCP Mutations Decouple Autophagy from Ubiquitin-Proteasome Crosstalk\n\n**Title:** VCP/p97 ATPase mutations impair extraction of ubiquitinated autophagy substrates, causing proteasome-autophagy flux obstruction\n\n**Mechanism:** VCP extracts ubiquitinated proteins from ER membranes and protein aggregates for proteasomal degradation. ALS-causing VCP mutations (e.g., R155H) reduce ATPase activity and alter substrate recognition. This disrupts the coordination between proteasomal and autophagic clearance pathways, causing ubiquitinated proteins to accumulate in aggresome-like structures that overwhelm remaining autophagy capacity—particularly damaging in neurons where protein turnover is already stressed.\n\n**Target gene/protein/pathway:** VCP (hexamer) → p62/SQSTM1 → ubiquitinated protein aggregates → proteasome/autophagy\n\n**Supporting evidence:**\n- VCP mutations cause familial ALS (PMID: 20562850, 20180545)\n- VCP regulates autophagosome maturation (PMID: 20818175)\n- VCP mutations cause ubiquitin-positive nuclear and cytoplasmic inclusions (PMID: 21305278)\n- p62 body formation is enhanced but clearance impaired (PMID: 27466187)\n\n**Predicted experiment:** Proteomic analysis of VCP-associated complexes in motor neurons from VCP R155H knock-in mice using TurboID labeling, with quantitative assessment of ubiquitinated substrate flux through proteasome vs. autophagy pathways over time.\n\n**Confidence:** 0.",
  "tokens_used": "1414",
  "persona_id": "persona-theorist"
}